Esomeprazole and omeprazole could boost the serum concentrations of benzodiazepines (by way of CYP2C19 inhibition) resulting in enhanced adverse effects such as drowsiness, although the scientific relevance is low in most patients – monitor the patient for adverse effects (e.If client can not resume their typical oral medication article-operative